Clinical trial
Comparing Angiomax to Heparin With Protamine in Patients Undergoing…
NCT00079586 · The Medicines Company, Industry · Completed
Key facts
| NCT number | NCT00079586 |
|---|---|
| Title | Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB) |
| Official title | A Study Comparing Angiomax (Bivalirudin) to Heparin With Protamine Reversal in Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass (CPB) |
| Lead sponsor | The Medicines Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Disease, Coronary Artery Bypass Surgery |
| Intervention type | Drug |
| Interventions | Heparin, Bivalirudin |
| Enrollment | 150 |
| Start date | Apr 1, 2004 |
| Completion | Nov 1, 2004 |
| First posted | Mar 11, 2004 |
| Last update posted | Jan 5, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: